ReviewCureus2025
Sex and Gender Differences in Face and Upper Extremity Allotransplantation: A Narrative Review of Implications and Impact.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immunological considerations and outcomes in cross-sex vascularized composite allotransplantation.Clinical transplantation and research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sex and gender differences play a significant role in vascularized composite allotransplantation (VCA), impacting both surgical outcomes and postoperative care. While sex refers to biological distinctions and gender encompasses life experiences and behaviors, both factors are closely interrelated in transplantation. Biological sex differences, such as immune responses, hormonal fluctuations, and anatomical features influence graft adaptation and healing, while both sex and gender-specific factors affect psychological and functional recovery. Studies indicate that men have higher mortality and reoperation rates, whereas women are more susceptible to adverse effects from immunosuppressive therapies. Unlike solid organ transplantation (SOT), which is primarily lifesaving, VCA focuses on life-enhancing outcomes, requiring careful attention to patients' social, psychological, and functional well-being. Lifelong immunosuppression in VCA carries risks, including infections and cancer, complicating patient management. Psychological readiness is crucial for candidate selection and long-term success, with women often expressing greater concerns about outcomes. Although no significant gender differences in functional recovery have been observed, individualized rehabilitation plans based on anatomical and physiological differences remain essential for optimal recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.